These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11996793)

  • 1. Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene.
    Dubourg C; Toutain B; Hélias C; Henry C; Lessard M; Le Gall JY; Le Treut A; Guenet L
    Cancer Genet Cytogenet; 2002 Apr; 134(1):33-7. PubMed ID: 11996793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eukaryotic translation termination factor gene (ETF1/eRF1) maps at D5S500 in a commonly deleted region of chromosome 5q31 in malignant myeloid diseases.
    Guenet L; Henry C; Toutain B; Dubourg C; Le Gall JY; David V; Le Treut A
    Cytogenet Cell Genet; 2000; 88(1-2):82-6. PubMed ID: 10773672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60.
    Zavadil J; Brezinová J; Svoboda P; Zemanová Z; Michalová K
    Leukemia; 1997 Aug; 11(8):1187-92. PubMed ID: 9264367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
    Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia.
    Lezon-Geyda K; Najfeld V; Johnson EM
    Leukemia; 2001 Jun; 15(6):954-62. PubMed ID: 11417483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the 5q- chromosome.
    Nagarajan L
    Leuk Lymphoma; 1995 May; 17(5-6):361-6. PubMed ID: 7549826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval.
    Horrigan SK; Westbrook CA; Kim AH; Banerjee M; Stock W; Larson RA
    Blood; 1996 Oct; 88(7):2665-70. PubMed ID: 8839861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31.
    Horrigan SK; Arbieva ZH; Xie HY; Kravarusic J; Fulton NC; Naik H; Le TT; Westbrook CA
    Blood; 2000 Apr; 95(7):2372-7. PubMed ID: 10733509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor.
    Hejlik DP; Kottickal LV; Liang H; Fairman J; Davis T; Janecki T; Sexton D; Perry W; Tavtigian SV; Teng DH; Nagarajan L
    Cancer Res; 1997 Sep; 57(17):3779-83. PubMed ID: 9288787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
    Lai F; Godley LA; Joslin J; Fernald AA; Liu J; Espinosa R; Zhao N; Pamintuan L; Till BG; Larson RA; Qian Z; Le Beau MM
    Genomics; 2001 Jan; 71(2):235-45. PubMed ID: 11161817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
    Willman CL; Sever CE; Pallavicini MG; Harada H; Tanaka N; Slovak ML; Yamamoto H; Harada K; Meeker TC; List AF
    Science; 1993 Feb; 259(5097):968-71. PubMed ID: 8438156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
    Pedersen B
    Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
    Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
    Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
    MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
    Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).
    Jarosova M; Nedomova R; Hubacek J; Holzerova M; Mickova P; Katrincsakova B; Pikalova Z; Papajik T; Indrak K
    Leuk Res; 2012 Apr; 36(4):e68-70. PubMed ID: 22284693
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of point mutations within the AML-1 gene in patients with MDS/AML and loss of chromosome 5q or 7.
    Ferrari T; Weber B; Pils S; Harbott J; Borkhardt A
    Ann Hematol; 2001 Feb; 80(2):72-3. PubMed ID: 11261327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ.
    Soenen V; Preudhomme C; Roumier C; Daudignon A; Laï JL; Fenaux P
    Blood; 1998 Feb; 91(3):1008-15. PubMed ID: 9446663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.